Cerus CERS
NASDAQ CERS
$2.51 -0.03 (-1.18%)
As of: Sep 9, 2026 · 3:59 PM EDT

Cerus (CERS) Total Non-Current Liabilities (2010 - 2026)

Cerus' (CERS) quarterly Total Non-Current Liabilities came in at $129.3 million in Q2 2026, down 15.26% year-over-year from $152.5 million in Q2 2025, and down 13.37% quarter-over-quarter from $149.2 million in Q1 2026.

Analysis

Cerus (CERS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Cerus has disclosed Total Non-Current Liabilities across 17 years of filings, most recently posting $129.3 million for Q2 2026.

  • In Q2 2026, Total Non-Current Liabilities fell 15.26% year-over-year to $129.3 million; the TTM figure through Jun 2026 stood at $129.3 million (down 15.26% YoY), while the FY2025 annual figure was $151.5 million, up 8.11% from the prior year.
  • Total Non-Current Liabilities came in at $129.3 million for Q2 2026 at Cerus, down from $149.2 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $154.0 million in Q3 2023 to a low of $129.3 million in Q2 2026.
  • Average Total Non-Current Liabilities over 5 years is $142.3 million, with a median of $142.7 million recorded in 2023.
  • Year-over-year, Total Non-Current Liabilities gained 15.92% in 2025 and slipped 15.26% in 2026.
  • Over 5 years, Total Non-Current Liabilities stood at $146.0 million in 2022, then retreated by 3.4% to $141.1 million in 2023, then dropped by 0.66% to $140.1 million in 2024, then increased by 8.11% to $151.5 million in 2025, then dropped by 14.68% to $129.3 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $129.3 million in Q2 2026, $149.2 million in Q1 2026, and $151.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 1.92 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 40.46 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 2.57 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 6.34 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 3.68 Bn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 3.44 Bn
10 Cerus 521.95 Mn 466.38 Mn 29.53 Mn 129.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 129.25 Mn
Mar 31, 2026 149.20 Mn
Dec 31, 2025 151.50 Mn
Sep 30, 2025 147.76 Mn
Jun 30, 2025 152.53 Mn
Mar 31, 2025 146.51 Mn
Dec 31, 2024 140.13 Mn
Sep 30, 2024 131.46 Mn
Jun 30, 2024 131.58 Mn
Mar 31, 2024 135.54 Mn
Dec 31, 2023 141.07 Mn
Sep 30, 2023 153.99 Mn
Jun 30, 2023 144.37 Mn
Mar 31, 2023 147.36 Mn
Dec 31, 2022 146.03 Mn
Sep 30, 2022 138.08 Mn
Jun 30, 2022 136.57 Mn
Mar 31, 2022 138.22 Mn
Dec 31, 2021 149.54 Mn
Sep 30, 2021 135.47 Mn